BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28259295)

  • 1. Risk assessment in paediatric glioma-Time to move on from the binary classification.
    Dodgshun AJ; Hansford JR; Sullivan MJ
    Crit Rev Oncol Hematol; 2017 Mar; 111():52-59. PubMed ID: 28259295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in Pediatric Glioma Pathology.
    Hakar MH; Wood MD
    Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade gliomas.
    Schiff D
    J Neurosurg; 2011 Nov; 115(5):945-7; author reply 947. PubMed ID: 21854121
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-grade gliomas -- current concepts.
    Schramm J; Blümcke I; Ostertag CB; Schlegel U; Simon M; Lutterbach J
    Zentralbl Neurochir; 2006 May; 67(2):55-66. PubMed ID: 16673237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of age group classification for risk stratification in glioma patients.
    Lin Z; Yang R; Li K; Yi G; Li Z; Guo J; Zhang Z; Junxiang P; Liu Y; Qi S; Huang G
    BMC Neurol; 2020 Aug; 20(1):310. PubMed ID: 32819307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection.
    Hervey-Jumper SL; Li J; Osorio JA; Lau D; Molinaro AM; Benet A; Berger MS
    J Neurosurg; 2016 Feb; 124(2):482-8. PubMed ID: 26339856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of different classification standards of age groups on prognosis in high-grade hemispheric glioma patients.
    Chen JW; Zhou CF; Lin ZX
    J Neurol Sci; 2015 Sep; 356(1-2):148-52. PubMed ID: 26143529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis to complement histopathological diagnosis of brain tumors.
    Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
    Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
    Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
    Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in brainstem gliomas.
    Cohen ME; Duffner PK; Heffner RR; Lacey DJ; Brecher M
    Neurology; 1986 May; 36(5):602-5. PubMed ID: 3703258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis.
    Koriyama S; Nitta M; Kobayashi T; Muragaki Y; Suzuki A; Maruyama T; Komori T; Masui K; Saito T; Yasuda T; Hosono J; Okamoto S; Shioyama T; Yamatani H; Kawamata T
    Brain Tumor Pathol; 2018 Jul; 35(3):159-167. PubMed ID: 29980868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
    Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
    J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade glial tumors: are they all the same?
    Bristol RE
    Semin Pediatr Neurol; 2009 Mar; 16(1):23-6. PubMed ID: 19410153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system gliomas.
    Reni M; Mazza E; Zanon S; Gatta G; Vecht CJ
    Crit Rev Oncol Hematol; 2017 May; 113():213-234. PubMed ID: 28427510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical ramifications of "genomic staging" of low-grade gliomas.
    Verma V; Mehta MP
    J Neurooncol; 2016 Sep; 129(2):195-9. PubMed ID: 27401152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.